 |
PDBsum entry 1xa6
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein
|
PDB id
|
|
|
|
1xa6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Signaling protein
|
 |
|
Title:
|
 |
Crystal structure of the human beta2-chimaerin
|
|
Structure:
|
 |
Beta2-chimaerin. Chain: a. Synonym: beta-chimerin, rho-gtpase-activating protein 3. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108.
|
|
Resolution:
|
 |
|
3.20Å
|
R-factor:
|
0.252
|
R-free:
|
0.298
|
|
|
Authors:
|
 |
B.Canagarajah,F.C.Leskow,J.Y.Ho,H.Mischak,L.F.Saidi,M.G.Kazanietz, J.H.Hurley
|
Key ref:
|
 |
B.Canagarajah
et al.
(2004).
Structural mechanism for lipid activation of the Rac-specific GAP, beta2-chimaerin.
Cell,
119,
407-418.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
25-Aug-04
|
Release date:
|
23-Nov-04
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P52757
(CHIO_HUMAN) -
Beta-chimaerin from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
468 a.a.
399 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Cell
119:407-418
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural mechanism for lipid activation of the Rac-specific GAP, beta2-chimaerin.
|
|
B.Canagarajah,
F.C.Leskow,
J.Y.Ho,
H.Mischak,
L.F.Saidi,
M.G.Kazanietz,
J.H.Hurley.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The lipid second messenger diacylglycerol acts by binding to the C1 domains of
target proteins, which translocate to cell membranes and are allosterically
activated. Here we report the crystal structure at 3.2 A resolution of one such
protein, beta2-chimaerin, a GTPase-activating protein for the small GTPase Rac,
in its inactive conformation. The structure shows that in the inactive state,
the N terminus of beta2-chimaerin protrudes into the active site of the RacGAP
domain, sterically blocking Rac binding. The diacylglycerol and phospholipid
membrane binding site on the C1 domain is buried by contacts with the four
different regions of beta2-chimaerin: the N terminus, SH2 domain, RacGAP domain,
and the linker between the SH2 and C1 domains. Phospholipid binding to the C1
domain triggers the cooperative dissociation of these interactions, allowing the
N terminus to move out of the active site and thereby activating the enzyme.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Structure of β2-Chimaerin(A) Refined model of
β2-chimaerin in the vicinity of Gln32 superimposed on the
solvent-modified single anomalous dispersion (SAD) Fourier
synthesis.(B) Overall structure of β2-chimaerin. The domains
red (SH2), blue (C1), green (RacGAP), and grey (linkers).(C)
Structure of the SH2 domain (red) overlaid on the SH2 domain of
Src (cyan) and showing the internal phosphotyrosine-containing
sequence in Src in a stick representation.(D) Structure of the
C1 domain (blue) overlaid on the C1B domain of PKCδ (cyan) and
showing phorbol ester as bound to the the PKCδ-C1B.(E)
Structure of the RacGAP domain (green) overlaid on the RhoGAP
domain of p50RhoGAP (grey), showing the bound Cdc42 protein
(yellow) in complex with GDP and AlF[x]^− (stick model).(F)
Linker regions are shown in a worm represenation, with the rest
of β2-chimaerin shown in a space-filling representation,
oriented and colored as in (B).
|
 |
Figure 7.
Figure 7. Autoinhibition and Activation of the RacGAP
Domain(A) Pro21 and Pro22 (yellow stick model) of β2-chimaerin,
overlaid on the docked structure of Rac (translucent surface and
model).(B) The αF′ helix in the observed conformation (green)
and predicted active conformation (cyan and translucent), with
the N-terminal region in gray.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Cell
(2004,
119,
407-418)
copyright 2004.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
T.A.Leonard,
B.Różycki,
L.F.Saidi,
G.Hummer,
and
J.H.Hurley
(2011).
Crystal structure and allosteric activation of protein kinase C βII.
|
| |
Cell,
144,
55-66.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.O'Donnell,
R.K.Chance,
and
G.J.Bashaw
(2009).
Axon growth and guidance: receptor regulation and signal transduction.
|
| |
Annu Rev Neurosci,
32,
383-412.
|
 |
|
|
|
|
 |
M.S.Sosa,
N.E.Lewin,
S.H.Choi,
P.M.Blumberg,
and
M.G.Kazanietz
(2009).
Biochemical characterization of hyperactive beta2-chimaerin mutants revealed an enhanced exposure of C1 and Rac-GAP domains.
|
| |
Biochemistry,
48,
8171-8178.
|
 |
|
|
|
|
 |
M.Siliceo,
and
I.Mérida
(2009).
T Cell Receptor-dependent Tyrosine Phosphorylation of {beta}2-Chimaerin Modulates Its Rac-GAP Function in T Cells.
|
| |
J Biol Chem,
284,
11354-11363.
|
 |
|
|
|
|
 |
R.V.Stahelin
(2009).
Lipid binding domains: more than simple lipid effectors.
|
| |
J Lipid Res,
50,
S299-S304.
|
 |
|
|
|
|
 |
Y.Tong,
P.K.Hota,
J.Y.Penachioni,
M.B.Hamaneh,
S.Kim,
R.S.Alviani,
L.Shen,
H.He,
W.Tempel,
L.Tamagnone,
H.W.Park,
and
M.Buck
(2009).
Structure and function of the intracellular region of the plexin-b1 transmembrane receptor.
|
| |
J Biol Chem,
284,
35962-35972.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Duan,
D.M.Sigano,
J.A.Kelley,
C.C.Lai,
N.E.Lewin,
N.Kedei,
M.L.Peach,
J.Lee,
T.P.Abeyweera,
S.A.Rotenberg,
H.Kim,
Y.H.Kim,
S.El Kazzouli,
J.U.Chung,
H.A.Young,
M.R.Young,
A.Baker,
N.H.Colburn,
A.Haimovitz-Friedman,
J.P.Truman,
D.A.Parrish,
J.R.Deschamps,
N.A.Perry,
R.J.Surawski,
P.M.Blumberg,
and
V.E.Marquez
(2008).
Conformationally constrained analogues of diacylglycerol. 29. Cells sort diacylglycerol-lactone chemical zip codes to produce diverse and selective biological activities.
|
| |
J Med Chem,
51,
5198-5220.
|
 |
|
|
|
|
 |
F.Colón-González,
F.C.Leskow,
and
M.G.Kazanietz
(2008).
Identification of an Autoinhibitory Mechanism That Restricts C1 Domain-mediated Activation of the Rac-GAP {alpha}2-Chimaerin.
|
| |
J Biol Chem,
283,
35247-35257.
|
 |
|
|
|
|
 |
M.J.Caloca,
P.Delgado,
B.Alarcón,
and
X.R.Bustelo
(2008).
Role of chimaerins, a group of Rac-specific GTPase activating proteins, in T-cell receptor signaling.
|
| |
Cell Signal,
20,
758-770.
|
 |
|
|
|
|
 |
N.Miyake,
J.Chilton,
M.Psatha,
L.Cheng,
C.Andrews,
W.M.Chan,
K.Law,
M.Crosier,
S.Lindsay,
M.Cheung,
J.Allen,
N.J.Gutowski,
S.Ellard,
E.Young,
A.Iannaccone,
B.Appukuttan,
J.T.Stout,
S.Christiansen,
M.L.Ciccarelli,
A.Baldi,
M.Campioni,
J.C.Zenteno,
D.Davenport,
L.E.Mariani,
M.Sahin,
S.Guthrie,
and
E.C.Engle
(2008).
Human CHN1 mutations hyperactivate alpha2-chimaerin and cause Duane's retraction syndrome.
|
| |
Science,
321,
839-843.
|
 |
|
|
|
|
 |
S.H.Choi,
G.Czifra,
N.Kedei,
N.E.Lewin,
J.Lazar,
Y.Pu,
V.E.Marquez,
and
P.M.Blumberg
(2008).
Characterization of the interaction of phorbol esters with the C1 domain of MRCK (myotonic dystrophy kinase-related Cdc42 binding kinase) alpha/beta.
|
| |
J Biol Chem,
283,
10543-10549.
|
 |
|
|
|
|
 |
A.A.Beg,
J.E.Sommer,
J.H.Martin,
and
P.Scheiffele
(2007).
alpha2-Chimaerin is an essential EphA4 effector in the assembly of neuronal locomotor circuits.
|
| |
Neuron,
55,
768-778.
|
 |
|
|
|
|
 |
A.Wagner
(2007).
Rapid detection of positive selection in genes and genomes through variation clusters.
|
| |
Genetics,
176,
2451-2463.
|
 |
|
|
|
|
 |
D.Colinet,
A.Schmitz,
D.Depoix,
D.Crochard,
and
M.Poirié
(2007).
Convergent use of RhoGAP toxins by eukaryotic parasites and bacterial pathogens.
|
| |
PLoS Pathog,
3,
e203.
|
 |
|
|
|
|
 |
D.R.Dries,
L.L.Gallegos,
and
A.C.Newton
(2007).
A single residue in the C1 domain sensitizes novel protein kinase C isoforms to cellular diacylglycerol production.
|
| |
J Biol Chem,
282,
826-830.
|
 |
|
|
|
|
 |
H.Wegmeyer,
J.Egea,
N.Rabe,
H.Gezelius,
A.Filosa,
A.Enjin,
F.Varoqueaux,
K.Deininger,
F.Schnütgen,
N.Brose,
R.Klein,
K.Kullander,
and
A.Betz
(2007).
EphA4-dependent axon guidance is mediated by the RacGAP alpha2-chimaerin.
|
| |
Neuron,
55,
756-767.
|
 |
|
|
|
|
 |
J.L.Bos,
H.Rehmann,
and
A.Wittinghofer
(2007).
GEFs and GAPs: critical elements in the control of small G proteins.
|
| |
Cell,
129,
865-877.
|
 |
|
|
|
|
 |
S.Carrasco,
and
I.Mérida
(2007).
Diacylglycerol, when simplicity becomes complex.
|
| |
Trends Biochem Sci,
32,
27-36.
|
 |
|
|
|
|
 |
S.P.Bruinsma,
R.L.Cagan,
and
T.J.Baranski
(2007).
Chimaerin and Rac regulate cell number, adherens junctions, and ERK MAP kinase signaling in the Drosophila eye.
|
| |
Proc Natl Acad Sci U S A,
104,
7098-7103.
|
 |
|
|
|
|
 |
C.Yang,
Y.Liu,
M.A.Lemmon,
and
M.G.Kazanietz
(2006).
Essential role for Rac in heregulin beta1 mitogenic signaling: a mechanism that involves epidermal growth factor receptor and is independent of ErbB4.
|
| |
Mol Cell Biol,
26,
831-842.
|
 |
|
|
|
|
 |
F.C.Leskow,
B.A.Holloway,
H.Wang,
M.C.Mullins,
and
M.G.Kazanietz
(2006).
The zebrafish homologue of mammalian chimerin Rac-GAPs is implicated in epiboly progression during development.
|
| |
Proc Natl Acad Sci U S A,
103,
5373-5378.
|
 |
|
|
|
|
 |
H.Wang,
C.Yang,
F.C.Leskow,
J.Sun,
B.Canagarajah,
J.H.Hurley,
and
M.G.Kazanietz
(2006).
Phospholipase Cgamma/diacylglycerol-dependent activation of beta2-chimaerin restricts EGF-induced Rac signaling.
|
| |
EMBO J,
25,
2062-2074.
|
 |
|
|
|
|
 |
J.Das,
X.Zhou,
and
K.W.Miller
(2006).
Identification of an alcohol binding site in the first cysteine-rich domain of protein kinase Cdelta.
|
| |
Protein Sci,
15,
2107-2119.
|
 |
|
|
|
|
 |
J.H.Hurley
(2006).
Membrane binding domains.
|
| |
Biochim Biophys Acta,
1761,
805-811.
|
 |
|
|
|
|
 |
A.Toker
(2005).
The biology and biochemistry of diacylglycerol signalling. Meeting on molecular advances in diacylglycerol signalling.
|
| |
EMBO Rep,
6,
310-314.
|
 |
|
|
|
|
 |
C.Hall,
L.Lim,
and
T.Leung
(2005).
C1, see them all.
|
| |
Trends Biochem Sci,
30,
169-171.
|
 |
|
|
|
|
 |
C.Yang,
Y.Liu,
F.C.Leskow,
V.M.Weaver,
and
M.G.Kazanietz
(2005).
Rac-GAP-dependent inhibition of breast cancer cell proliferation by {beta}2-chimerin.
|
| |
J Biol Chem,
280,
24363-24370.
|
 |
|
|
|
|
 |
J.L.Oliva,
E.M.Griner,
and
M.G.Kazanietz
(2005).
PKC isozymes and diacylglycerol-regulated proteins as effectors of growth factor receptors.
|
| |
Growth Factors,
23,
245-252.
|
 |
|
|
|
|
 |
R.V.Stahelin,
J.Wang,
N.R.Blatner,
J.D.Rafter,
D.Murray,
and
W.Cho
(2005).
The origin of C1A-C2 interdomain interactions in protein kinase Calpha.
|
| |
J Biol Chem,
280,
36452-36463.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |